Αρχειοθήκη ιστολογίου

Παρασκευή 3 Νοεμβρίου 2017

Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells

ERBB2 is overexpressed in up to 20–30% of human breast cancers (BCs), and it is associated with aggressive disease. Trastuzumab (Tz), a humanized monoclonal antibody, improves the prognosis associated with ERB...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2ys2AZP

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου